| Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://doi.org/10.1128/MRA.01387-20 | Mutation Profile of SARS-CoV-2 Genome Sequences Originating from Eight Israeli Patient Isolates | Galia Zaide, Inbar Cohen-Gihon, Ofir Israeli, Dana Stein, Ohad Shifman, Shay Weiss, Irit Simon, Orly Laskar, Adi Beth-Din, Anat Zvi | 2021 | Microbiol Resour Announc. | |
| Screening of an FDA-Approved Library for Novel Drugs against Y. pestis | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://www.mdpi.com/2079-6382/10/1/40 | Screening of an FDA-Approved Library for Novel Drugs against Y. pestis | David Gur, Theodor Chitlaru, Emanuelle Mamroud, Ayelet Zauberman | 2021 | Antibiotics | |
| Characterization of Yersinia pestis Phage Lytic Activity in Human Whole Blood for the Selection of Efficient Therapeutic Phages | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://www.mdpi.com/1999-4915/13/1/89 | Characterization of Yersinia pestis Phage Lytic Activity in Human Whole Blood for the Selection of Efficient Therapeutic Phages | Sarit Moses, Yaron Vagima, Avital Tidhar, Emanuelle Mamroud, Shahar Rotem, Ida Steinberger-Levy | 2021 | Viruses | |
| New approach for the rational selection of markers to identify botulinum toxins | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://pubmed.ncbi.nlm.nih.gov/33569691/ | New approach for the rational selection of markers to identify botulinum toxins | Osnat Rosen, Liron Feldberg, Eyal Dor, Ran Zichel | 2021 | Archives of Toxicology | |
| Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://pubs.acs.org/doi/abs/10.1021/acsomega.0c04691 | Specific and Rapid SARS-CoV-2 Identification Based on LC-MS/MS Analysis | Ofir Schuster, Anat Zvi, Osnat Rosen, Hagit Achdout, Amir Ben-Shmuel, Ohad Shifman, Shmuel Yitzhaki, Orly Laskar, Liron Feldberg* | 2021 | ACSPublications | |
| Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://www.mdpi.com/2076-0817/10/3/285 | Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection | Adva Mechaly ,Einat B. Vitner,Yinon Levy, David Gur, Moria Barlev-Gross, Assa Sittner, Michal Koren, Haim Levy, Emanuelle Mamroud, Morly Fisher | 2021 | Pathogens | |
| Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/chimical.svg" style="BORDER:0px solid;" /> | https://www.sciencedirect.com/science/article/pii/S0378517321004944?via%3Dihub | Towards catch-up therapy: evaluation of nucleophilic active pharmaceutical ingredients for the treatment of percutaneous VX poisoning, in-vial and in-vitro studies | Victoria Nahum, Uri Nili, Eugenia Bloch-Shilderm, Boris Smolkin, Nissan Ashkenazi | 2021 | International Journal of Pharmaceutics | |
| Pathophysiological profile of awake and anesthetized pigs following systemic exposure to the highly lethal ricin toxin | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/chimical.svg" style="BORDER:0px solid;" /> | https://www.tandfonline.com/doi/full/10.1080/15563650.2021.1933513 | Pathophysiological profile of awake and anesthetized pigs following systemic exposure to the highly lethal ricin toxin | Reut Falach, Michael Goldvaser, Pinchas Halpern, Amir Rosner, Anita Sapoznikov, Yoav Gal, Orr Goren, Tamar Sabo, Chanoch Kronman, Shahaf Katalan | 2021 | | |
| A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://www.nature.com/articles/s41467-020-20228-7 | A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge | at Yahalom-Ronen, Hadas Tamir, Sharon Melamed, Boaz Politi, Ohad Shifman, Hagit Achdout, Einat B. Vitner, Ofir Israeli, Elad Milrot, Dana Stein, Inbar Cohen-Gihon, Shlomi Lazar, Hila Gutman, Itai Glinert, Lilach Cherry, Yaron Vagima, Shirley Lazar, Shay W | 2021 | Nature Communacations | |
| Active and Strippable PVA/Borax/NaBO3 Hydrogel for Effective Containment and Decontamination of Chemical Warfare Agents | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/chimical.svg" style="BORDER:0px solid;" /> | https://pubs.acs.org/doi/10.1021/acsomega.0c05493 | Active and Strippable PVA/Borax/NaBO3 Hydrogel for Effective Containment and Decontamination of Chemical Warfare Agents | Orit Redy Keisar , Victoria Nahum , Lea Yehezkel , Itzhak Marcovitch , Ishay Columbus , Gil Fridkin, Ravit Chen | 2021 | ACSPublications | |
| A Rabbit Model for Prolonged Continuous Intravenous Infusion Via a Peripherally Inserted Central Catheter | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://pubmed.ncbi.nlm.nih.gov/33897426/ | A Rabbit Model for Prolonged Continuous Intravenous Infusion Via a Peripherally Inserted Central Catheter | Eyal Dor, Tseela David, Hani Dekel Jaoui, Arieh Schwartz, Tzadok Baruchi, Amram Torgeman, Alon Ben David, Osnat Rosen, Arnon Tal, Amir Rosner, Ran Zichel, Eran Diamant | 2021 | Front Pharmacol | |
| Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://www.sciencedirect.com/science/article/pii/S2589004221004478?via%3Dihub#! | Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice | Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, Moshe Aftalion, Reut Falach, Shani Leviatan Ben-Arye, Shirley Lazar, Ayelet Zauberman, Eyal Epstein, Theodor Chitlaru, Shay Weiss | 2021 | iScience | |
| Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://pubmed.ncbi.nlm.nih.gov/34072087/ | Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries | David BA, Diamant E, Dor E, Barnea A, Natan N, Levin L, Chapman S, Mimran LC, Epstein E, Zichel R, Torgeman A. | 2021 | Molecules | |
| Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA-peptidomics | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://www.sciencedirect.com/science/article/pii/S2211124721006811?via%3Dihub#! | Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA-peptidomics | Nagler A, Kalaora S, Barbolin C, Gangaev A, Ketelaars S.L.C, Alon M, Pai J, Benedek G, Yahalom-Ronen Y, Erez N, Greenberg P, Yagel G, Peri A, Levin Y, Satpathy A, Bar-Haim E, Paran N, Kvistborg P, Samuels Y | 2021 | Cell reports | |
| Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection | <img alt="" src="/Style%20Library/IIBR/img/svg-icons/biology.svg" style="BORDER:0px solid;" /> | https://pubs.acs.org/doi/10.1021/acs.nanolett.1c01284 | Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection | Elia U, Rotem S, Bar-Haim E, Ramishetti S, Somu Naidu G, Gur D, Aftalion M, Israeli M, Bercovich-Kinori A, Alcalay R, Makdasi E, Chitlaru T, Rosenfeld R, Israely T, Melamed S, Abutbul Ionita I, Danino D, Peer D, Cohen O | 2021 | ACSPublications | |